Published in Arch Gen Psychiatry on March 01, 2004
We don't train in vain: a dissemination trial of three strategies of training clinicians in cognitive-behavioral therapy. J Consult Clin Psychol (2005) 4.71
Computer-assisted delivery of cognitive-behavioral therapy for addiction: a randomized trial of CBT4CBT. Am J Psychiatry (2008) 3.74
Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial. Arch Gen Psychiatry (2009) 3.61
Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials. Addiction (2011) 3.42
Direct care workers in the National Drug Abuse Treatment Clinical Trials Network: characteristics, opinions, and beliefs. Psychiatr Serv (2007) 3.38
Site matters: multisite randomized trial of motivational enhancement therapy in community drug abuse clinics. J Consult Clin Psychol (2007) 2.98
Behavioral therapies for drug abuse. Am J Psychiatry (2005) 2.75
Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Biochem Pharmacol (2007) 2.18
Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials. J Stud Alcohol Drugs (2009) 1.94
Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial. Drug Alcohol Depend (2008) 1.59
Neurobiologic processes in drug reward and addiction. Harv Rev Psychiatry (2005) 1.47
What is usual about "treatment-as-usual"? Data from two multisite effectiveness trials. J Subst Abuse Treat (2008) 1.45
Making consent more informed: preliminary results from a multiple-choice test among probation-referred marijuana users entering a randomized clinical trial. J Am Acad Psychiatry Law (2008) 1.33
Clinical care of the HIV-infected drug user. Infect Dis Clin North Am (2007) 1.30
Choosing a behavioral therapy platform for pharmacotherapy of substance users. Drug Alcohol Depend (2004) 1.28
Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine β-hydroxylase. Biol Psychiatry (2012) 1.27
Disulfiram attenuates drug-primed reinstatement of cocaine seeking via inhibition of dopamine β-hydroxylase. Neuropsychopharmacology (2010) 1.27
D-Cycloserine attenuates reactivity to smoking cues in nicotine dependent smokers: a pilot investigation. Drug Alcohol Depend (2009) 1.27
Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform. Drug Alcohol Depend (2007) 1.26
The search for medications to treat stimulant dependence. Addict Sci Clin Pract (2008) 1.25
mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse. Mol Interv (2009) 1.23
Norepinephrine and stimulant addiction. Addict Biol (2008) 1.21
Effects of dopamine beta-hydroxylase genotype and disulfiram inhibition on catecholamine homeostasis in mice. Psychopharmacology (Berl) (2005) 1.20
Gender differences in cardiovascular and corticoadrenal response to stress and drug cues in cocaine dependent individuals. Psychopharmacology (Berl) (2006) 1.19
Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence. J Subst Abuse Treat (2007) 1.18
Practice makes progress? Homework assignments and outcome in treatment of cocaine dependence. J Consult Clin Psychol (2005) 1.17
Naltrexone and combined behavioral intervention effects on trajectories of drinking in the COMBINE study. Drug Alcohol Depend (2009) 1.16
The alliance in motivational enhancement therapy and counseling as usual for substance use problems. J Consult Clin Psychol (2009) 1.16
Severity of childhood trauma is predictive of cocaine relapse outcomes in women but not men. Drug Alcohol Depend (2007) 1.15
Treatment process, alliance and outcome in brief versus extended treatments for marijuana dependence. Addiction (2010) 1.12
Cognitive function and treatment response in a randomized clinical trial of computer-based training in cognitive-behavioral therapy. Subst Use Misuse (2011) 1.12
A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence. Addict Behav (2007) 1.11
Norepinephrine signaling through beta-adrenergic receptors is critical for expression of cocaine-induced anxiety. Biol Psychiatry (2008) 1.11
Cost-effectiveness of computer-assisted training in cognitive-behavioral therapy as an adjunct to standard care for addiction. Drug Alcohol Depend (2010) 1.10
Toward empirical identification of a clinically meaningful indicator of treatment outcome: features of candidate indicators and evaluation of sensitivity to treatment effects and relationship to one year follow up cocaine use outcomes. Drug Alcohol Depend (2014) 1.10
Disulfiram effects on responses to intravenous cocaine administration. Drug Alcohol Depend (2006) 1.09
Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients. Drug Alcohol Depend (2010) 1.08
Anti-relapse medications: preclinical models for drug addiction treatment. Pharmacol Ther (2009) 1.08
Neurobiological dissociation of retrieval and reconsolidation of cocaine-associated memory. J Neurosci (2013) 1.07
Review. Evidence-based treatments of addiction. Philos Trans R Soc Lond B Biol Sci (2008) 1.07
Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate. Pharmacol Ther (2012) 1.04
Combination of Modafinil and d-amphetamine for the Treatment of Cocaine Dependence: A Preliminary Investigation. Front Psychiatry (2012) 1.03
Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine. Am J Drug Alcohol Abuse (2009) 1.02
How can we use our knowledge of alcohol-tobacco interactions to reduce alcohol use? Annu Rev Clin Psychol (2012) 1.01
The selective dopamine β-hydroxylase inhibitor nepicastat attenuates multiple aspects of cocaine-seeking behavior. Neuropsychopharmacology (2013) 1.01
Enhancing brief cognitive-behavioral therapy with motivational enhancement techniques in cocaine users. Drug Alcohol Depend (2007) 1.01
Behavioral therapies for co-occurring substance use and mood disorders. Biol Psychiatry (2004) 0.97
The effects of oral micronized progesterone on smoked cocaine self-administration in women. Horm Behav (2010) 0.97
Pilot study of treatment for major depression among women prisoners with substance use disorder. J Psychiatr Res (2012) 0.96
Intraclass correlation associated with therapists: estimates and applications in planning psychotherapy research. Cogn Behav Ther (2011) 0.96
Motivational enhancement therapy coupled with cognitive behavioral therapy versus brief advice: a randomized trial for treatment of hazardous substance use in pregnancy and after delivery. Gen Hosp Psychiatry (2012) 0.95
Spending on substance abuse treatment: how much is enough? Addiction (2005) 0.95
Efficacy of disulfiram and Twelve Step Facilitation in cocaine-dependent individuals maintained on methadone: a randomized placebo-controlled trial. Drug Alcohol Depend (2012) 0.94
Psychological interventions for antisocial personality disorder. Cochrane Database Syst Rev (2010) 0.94
Safety, tolerability and efficacy of levodopa-carbidopa treatment for cocaine dependence: two double-blind, randomized, clinical trials. Drug Alcohol Depend (2006) 0.92
Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers. Int J Neuropsychopharmacol (2008) 0.92
The impact of disulfiram treatment on the reinforcing effects of cocaine: a randomized clinical trial. PLoS One (2012) 0.92
Are Internet use and video-game-playing addictive behaviors? Biological, clinical and public health implications for youths and adults. Minerva Psichiatr (2012) 0.92
Psychostimulant addiction treatment. Neuropharmacology (2014) 0.91
Disulfiram efficacy in the treatment of alcohol dependence: a meta-analysis. PLoS One (2014) 0.90
Treatment of co-occurring alcohol and other drug use disorders. Alcohol Res Health (2008) 0.90
Retracted Recent advances for the treatment of cocaine abuse: central nervous system immunopharmacotherapy. AAPS J (2005) 0.90
Disulfiram stimulates dopamine release from noradrenergic terminals and potentiates cocaine-induced dopamine release in the prefrontal cortex. Psychopharmacology (Berl) (2011) 0.89
Treatment of cocaine withdrawal anxiety with guanfacine: relationships to cocaine intake and reinstatement of cocaine seeking in rats. Psychopharmacology (Berl) (2012) 0.89
Topiramate in the treatment of substance-related disorders: a critical review of the literature. J Clin Psychiatry (2010) 0.88
Biomarkers for the development of new medications for cocaine dependence. Neuropsychopharmacology (2013) 0.87
Evaluation of the "Pipeline" for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research. Pharmacol Rev (2016) 0.87
Modifying the role of serotonergic 5-HTTLPR and TPH2 variants on disulfiram treatment of cocaine addiction: a preliminary study. Genes Brain Behav (2012) 0.86
Determining the primary endpoint for a stimulant abuse trial: lessons learned from STRIDE (CTN 0037). Am J Drug Alcohol Abuse (2011) 0.85
Only connect: The working alliance in computer-based cognitive behavioral therapy. Behav Res Ther (2014) 0.85
A double-blind, placebo-controlled assessment of the safety of potential interactions between intravenous cocaine, ethanol, and oral disulfiram. Drug Alcohol Depend (2011) 0.85
Assessment concordance and predictive validity of self-report and biological assay of cocaine use in treatment trials. Am J Addict (2014) 0.85
Gender differences in clinical outcomes for cocaine dependence: randomized clinical trials of behavioral therapy and disulfiram. Drug Alcohol Depend (2014) 0.84
Determination of GABA, glutamate and carbamathione in brain microdialysis samples by capillary electrophoresis with fluorescence detection. Electrophoresis (2011) 0.84
Disulfiram enhances subjective effects of dextroamphetamine in humans. Pharmacol Biochem Behav (2008) 0.84
A controlled trial of the adjunct use of D-cycloserine to facilitate cognitive behavioral therapy outcomes in a cocaine-dependent population. Addict Behav (2012) 0.84
Future pharmacological treatments for substance use disorders. Br J Clin Pharmacol (2014) 0.83
Personality disorders as maladaptive, extreme variants of normal personality: borderline personality disorder and neuroticism in a substance using sample. J Pers Disord (2013) 0.83
Medications for substance use disorders. Soc Work Public Health (2013) 0.82
LC-MS/MS method for the determination of carbamathione in human plasma. J Pharm Biomed Anal (2010) 0.82
New pharmacotherapies for treating the neurobiology of alcohol and drug addiction. Psychiatry (Edgmont) (2006) 0.82
A randomized factorial trial of disulfiram and contingency management to enhance cognitive behavioral therapy for cocaine dependence. Drug Alcohol Depend (2016) 0.82
Effects of pharmacologic dopamine β-hydroxylase inhibition on cocaine-induced reinstatement and dopamine neurochemistry in squirrel monkeys. J Pharmacol Exp Ther (2014) 0.81
[Cocaine abuse in Vienna and European cities--a multi-center study]. Wien Klin Wochenschr (2006) 0.81
S-(N, N-diethylcarbamoyl)glutathione (carbamathione), a disulfiram metabolite and its effect on nucleus accumbens and prefrontal cortex dopamine, GABA, and glutamate: a microdialysis study. Neuropharmacology (2013) 0.81
Lost in translation? Moving contingency management and cognitive behavioral therapy into clinical practice. Ann N Y Acad Sci (2014) 0.81
What happens in treatment doesn't stay in treatment: cocaine abstinence during treatment is associated with fewer problems at follow-up. J Consult Clin Psychol (2014) 0.81
Social workers and delivery of evidence-based psychosocial treatments for substance use disorders. Soc Work Public Health (2013) 0.81
New medications for the treatment of cocaine dependence. Psychiatry (Edgmont) (2005) 0.80
Neurocognitive indicators predict results of an informed-consent quiz among substance-dependent treatment seekers entering a randomized clinical trial. J Stud Alcohol Drugs (2010) 0.80
Chronic inhibition of dopamine β-hydroxylase facilitates behavioral responses to cocaine in mice. PLoS One (2012) 0.80
Pharmacogenetic randomized trial for cocaine abuse: disulfiram and α1A-adrenoceptor gene variation. Eur Neuropsychopharmacol (2013) 0.80
Pilot study of the effects of lisdexamfetamine on cocaine use: A randomized, double-blind, placebo-controlled trial. Drug Alcohol Depend (2015) 0.80
Increased Orbitofrontal Brain Activation after Administration of a Selective Adenosine A(2A) Antagonist in Cocaine Dependent Subjects. Front Psychiatry (2012) 0.80
Effects of prior cocaine self-administration on cognitive performance in female cynomolgus monkeys. Psychopharmacology (Berl) (2015) 0.80
Coping strategy use following computerized cognitive-behavioral therapy for substance use disorders. Psychol Addict Behav (2010) 0.79
ANKK1 and DRD2 pharmacogenetics of disulfiram treatment for cocaine abuse. Pharmacogenet Genomics (2013) 0.79
A review of pharmacogenetic studies of substance-related disorders. Drug Alcohol Depend (2015) 0.79
Therapeutic options and challenges for substances of abuse. Dialogues Clin Neurosci (2007) 0.79
Prompted to treatment by the criminal justice system: Relationships with treatment retention and outcome among cocaine users. Am J Addict (2015) 0.78
Intraclass correlations: uses in assessing rater reliability. Psychol Bull (1979) 71.07
The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J Consult Clin Psychol (2000) 7.71
The effects of psychosocial services in substance abuse treatment. JAMA (1993) 5.87
Ensuring balanced distribution of prognostic factors in treatment outcome research. J Stud Alcohol Suppl (1994) 5.79
Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset. Arch Gen Psychiatry (1993) 4.98
A general system for evaluating therapist adherence and competence in psychotherapy research in the addictions. Drug Alcohol Depend (2000) 4.92
One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence. Delayed emergence of psychotherapy effects. Arch Gen Psychiatry (1994) 3.20
Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction (1998) 2.88
Reliability and validity of 6-month timeline reports of cocaine and heroin use in a methadone population. J Consult Clin Psychol (1994) 2.75
A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance treatment for cocaine dependence. Arch Gen Psychiatry (2002) 2.64
Internal validity of Project MATCH treatments: discriminability and integrity. J Consult Clin Psychol (1998) 2.56
Implications of therapist effects for the design and analysis of comparative studies of psychotherapies. J Consult Clin Psychol (1991) 2.49
Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement. Arch Gen Psychiatry (2001) 2.29
Disulfiram treatment of alcoholism. A Veterans Administration cooperative study. JAMA (1986) 2.20
Improvement in naltrexone treatment compliance with contingency management. Drug Alcohol Depend (1999) 2.17
Psychotherapy for the treatment of depression: a comprehensive review of controlled outcome research. Psychol Bull (1990) 2.03
Comparative studies of psychotherapies. Is it true that "everywon has one and all must have prizes"? Arch Gen Psychiatry (1975) 2.00
One-year follow-up of disulfiram and psychotherapy for cocaine-alcohol users: sustained effects of treatment. Addiction (2000) 1.93
The validity of self-reported cocaine use in two groups of cocaine abusers. J Consult Clin Psychol (1999) 1.84
Psychotherapy and pharmacotherapy for ambulatory cocaine abusers. Arch Gen Psychiatry (1994) 1.81
Manual-guided psychosocial treatment. A new virtual requirement for pharmacotherapy trials? Arch Gen Psychiatry (1997) 1.74
Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer. Alcohol Clin Exp Res (1996) 1.67
Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts. Addiction (2000) 1.66
Concurrent and simultaneous use of alcohol with cocaine: results of national survey. Drug Alcohol Depend (1990) 1.60
Comparative outcome studies of psychotherapy: methodological issues and strategies. J Consult Clin Psychol (1986) 1.57
Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial. Biol Psychiatry (2000) 1.55
Can you trust patient self-reports of drug use during treatment? Drug Alcohol Depend (1994) 1.53
Disulfiram effects on acute cocaine administration. Drug Alcohol Depend (1998) 1.50
Alcohol dependence among cocaine-dependent outpatients: demographics, drug use, treatment outcome and other characteristics. J Stud Alcohol (2001) 1.48
Intention-to-treat meets missing data: implications of alternate strategies for analyzing clinical trials data. Drug Alcohol Depend (2002) 1.45
Alcoholism in treatment-seeking cocaine abusers: clinical and prognostic significance. J Stud Alcohol (1993) 1.40
Brief coping skills treatment for cocaine abuse: 12-month substance use outcomes. J Consult Clin Psychol (2000) 1.28
Superior efficacy of cognitive-behavioral therapy for urban crack cocaine abusers: main and matching effects. J Consult Clin Psychol (1998) 1.26
Behavioral, physiological, and pharmacological interaction of cocaine and disulfiram in humans. Biol Psychiatry (1995) 1.13
Cocaethylene: pharmacology, physiology and behavioral effects in humans. J Pharmacol Exp Ther (1995) 1.12
Features of cocaine dependence with concurrent alcohol abuse. Drug Alcohol Depend (1995) 1.12
Chronic disulfiram treatment effects on intranasal cocaine administration: initial results. Biol Psychiatry (1998) 1.11
Continuing care for cocaine dependence: comprehensive 2-year outcomes. J Consult Clin Psychol (1999) 1.11
Cocaethylene: a neuropharmacologically active metabolite associated with concurrent cocaine-ethanol ingestion. Life Sci (1991) 1.10
Group counseling versus individualized relapse prevention aftercare following intensive outpatient treatment for cocaine dependence: initial results. J Consult Clin Psychol (1997) 1.09
Alcohol pretreatment increases preference for cocaine over monetary reinforcement. Psychopharmacology (Berl) (1996) 1.07
The relationship of alcohol use to cocaine relapse in cocaine dependent patients in an aftercare study. J Stud Alcohol (1999) 1.02
Interpersonal psychotherapy adapted for ambulatory cocaine abusers. Am J Drug Alcohol Abuse (1985) 0.99
Treatment outcome of cocaine-alcohol dependent patients. Drug Alcohol Depend (1997) 0.98
Blind man's bluff: effectiveness and significance of psychotherapy and pharmacotherapy blinding procedures in a clinical trial. J Consult Clin Psychol (1994) 0.97
Disulfiram therapy in patients abusing cocaine and alcohol. Am J Psychiatry (1993) 0.92
Do psychotherapy and pharmacotherapy for depression conflict? Empirical evidence from a clinical trial. Arch Gen Psychiatry (1981) 0.88
Combined pharmacotherapy and psychotherapy. J Nerv Ment Dis (1969) 0.87
Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet (2010) 8.89
We don't train in vain: a dissemination trial of three strategies of training clinicians in cognitive-behavioral therapy. J Consult Clin Psychol (2005) 4.71
Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness study. Drug Alcohol Depend (2005) 4.65
Substance abuse and fathering: adding poppa to the research agenda. Addiction (2002) 3.94
Computer-assisted delivery of cognitive-behavioral therapy for addiction: a randomized trial of CBT4CBT. Am J Psychiatry (2008) 3.74
Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes. Arch Gen Psychiatry (2006) 3.55
Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug Alcohol Depend (2004) 3.09
Prize reinforcement contingency management for treating cocaine users: how low can we go, and with whom? Addiction (2004) 3.06
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet (2012) 3.04
Site matters: multisite randomized trial of motivational enhancement therapy in community drug abuse clinics. J Consult Clin Psychol (2007) 2.98
Bridging the gap: a hybrid model to link efficacy and effectiveness research in substance abuse treatment. Psychiatr Serv (2003) 2.77
Preliminary validity and reliability testing of a structured clinical interview for pathological gambling. Psychiatry Res (2004) 2.35
Community program therapist adherence and competence in motivational enhancement therapy. Drug Alcohol Depend (2008) 2.33
The use of contingency management and motivational/skills-building therapy to treat young adults with marijuana dependence. J Consult Clin Psychol (2006) 2.31
Varenicline reduces alcohol self-administration in heavy-drinking smokers. Biol Psychiatry (2009) 2.25
Training and fidelity monitoring of behavioral interventions in multi-site addictions research. Drug Alcohol Depend (2006) 2.24
A vision of the next generation of behavioral therapies research in the addictions. Addiction (2007) 2.09
MET meets the real world: design issues and clinical strategies in the Clinical Trials Network. J Subst Abuse Treat (2002) 2.08
Enduring effects of a computer-assisted training program for cognitive behavioral therapy: a 6-month follow-up of CBT4CBT. Drug Alcohol Depend (2008) 2.06
Pretreatment brain activation during stroop task is associated with outcomes in cocaine-dependent patients. Biol Psychiatry (2008) 2.04
A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users. Health Psychol (2003) 2.03
Modeling the effect of alcohol on smoking lapse behavior. Psychopharmacology (Berl) (2006) 1.95
Computer-assisted delivery of cognitive-behavioral therapy: efficacy and durability of CBT4CBT among cocaine-dependent individuals maintained on methadone. Am J Psychiatry (2014) 1.93
A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biol Psychiatry (2002) 1.86
Neural activity associated with stress-induced cocaine craving: a functional magnetic resonance imaging study. Psychopharmacology (Berl) (2005) 1.84
Initial and maintenance naltrexone treatment for alcohol dependence using primary care vs specialty care: a nested sequence of 3 randomized trials. Arch Intern Med (2003) 1.74
A multisite randomized effectiveness trial of motivational enhancement therapy for Spanish-speaking substance users. J Consult Clin Psychol (2009) 1.69
Mindfulness training for smoking cessation: results from a randomized controlled trial. Drug Alcohol Depend (2011) 1.68
Gambling urges in pathological gambling: a functional magnetic resonance imaging study. Arch Gen Psychiatry (2003) 1.63
Mindfulness training and stress reactivity in substance abuse: results from a randomized, controlled stage I pilot study. Subst Abus (2009) 1.62
Neuroscience of behavioral and pharmacological treatments for addictions. Neuron (2011) 1.57
Gambling: an addictive behavior with health and primary care implications. J Gen Intern Med (2002) 1.52
Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms. Biol Psychiatry (2006) 1.51
An initial study of neural responses to monetary incentives as related to treatment outcome in cocaine dependence. Biol Psychiatry (2011) 1.50
Correspondence of motivational enhancement treatment integrity ratings among therapists, supervisors, and observers. Psychother Res (2009) 1.49
A structured approach to medical management: a psychosocial intervention to support pharmacotherapy in the treatment of alcohol dependence. J Stud Alcohol Suppl (2005) 1.47
What is usual about "treatment-as-usual"? Data from two multisite effectiveness trials. J Subst Abuse Treat (2008) 1.45
Contingency management to enhance naltrexone treatment of opioid dependence: a randomized clinical trial of reinforcement magnitude. Exp Clin Psychopharmacol (2002) 1.44
Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking. Biol Psychiatry (2007) 1.42
Cost evaluation of evidence-based treatments. Addict Sci Clin Pract (2010) 1.42
Reasons for dropout from drug abuse treatment: symptoms, personality, and motivation. Addict Behav (2005) 1.36
A cognitive behavioral therapy for alcohol-dependent domestic violence offenders: an integrated substance abuse-domestic violence treatment approach (SADV). Am J Addict (2007) 1.33
Making consent more informed: preliminary results from a multiple-choice test among probation-referred marijuana users entering a randomized clinical trial. J Am Acad Psychiatry Law (2008) 1.33
Quality versus quantity: acquisition of coping skills following computerized cognitive-behavioral therapy for substance use disorders. Addiction (2010) 1.32
A randomized trial adapting contingency management targets based on initial abstinence status of cocaine-dependent patients. J Consult Clin Psychol (2012) 1.32
Errors in assessing DSM-IV substance use disorders. Arch Gen Psychiatry (2007) 1.31
Advisor-Teller Money Manager (ATM) therapy for substance use disorders. Psychiatr Serv (2010) 1.30
Choosing a behavioral therapy platform for pharmacotherapy of substance users. Drug Alcohol Depend (2004) 1.28
D-Cycloserine attenuates reactivity to smoking cues in nicotine dependent smokers: a pilot investigation. Drug Alcohol Depend (2009) 1.27
Computer-assisted therapy in psychiatry: be brave-it's a new world. Curr Psychiatry Rep (2010) 1.26
A methodological analysis of randomized clinical trials of computer-assisted therapies for psychiatric disorders: toward improved standards for an emerging field. Am J Psychiatry (2011) 1.26
Effect of transdermal nicotine replacement on alcohol responses and alcohol self-administration. Psychopharmacology (Berl) (2007) 1.24
Serious adverse events in randomized psychosocial treatment studies: safety or arbitrary edicts? J Consult Clin Psychol (2008) 1.20
Evaluating motivational enhancement therapy adherence and competence among Spanish-speaking therapists. Drug Alcohol Depend (2009) 1.20
Combining cognitive behavioral therapy with contingency management for smoking cessation in adolescent smokers: a preliminary comparison of two different CBT formats. Am J Addict (2007) 1.20
Teaching community program clinicians motivational interviewing using expert and train-the-trainer strategies. Addiction (2010) 1.20
Comorbidity of substance use with depression and other mental disorders: from Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) to DSM-V. Addiction (2006) 1.19
A preliminary study of the neural effects of behavioral therapy for substance use disorders. Drug Alcohol Depend (2011) 1.18
Practice makes progress? Homework assignments and outcome in treatment of cocaine dependence. J Consult Clin Psychol (2005) 1.17
Personality, substance of choice, and polysubstance involvement among substance dependent patients. Drug Alcohol Depend (2003) 1.16
Naltrexone and combined behavioral intervention effects on trajectories of drinking in the COMBINE study. Drug Alcohol Depend (2009) 1.16
The alliance in motivational enhancement therapy and counseling as usual for substance use problems. J Consult Clin Psychol (2009) 1.16
Ethyl glucuronide and ethyl sulfate assays in clinical trials, interpretation, and limitations: results of a dose ranging alcohol challenge study and 2 clinical trials. Alcohol Clin Exp Res (2014) 1.15
Severity of childhood trauma is predictive of cocaine relapse outcomes in women but not men. Drug Alcohol Depend (2007) 1.15
Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders. Biol Psychiatry (2005) 1.15
A perfect platform: combining contingency management with medications for drug abuse. Am J Drug Alcohol Abuse (2007) 1.14
Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry (2007) 1.14
Cognitive function and treatment response in a randomized clinical trial of computer-based training in cognitive-behavioral therapy. Subst Use Misuse (2011) 1.12